PharVision Advisers’s Tetra Tech TTEK Stock Holding History

PharVision Advisers’s Portfolio TTEK Stock Details TTEK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,517	Closed	-$218K	–	1012
2025 Q3	$218K	Buy	+6,517	New	+$237K	0.12%	443

Other funds holding TTEK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PharVision Advisers's TTEK Position: Q4 2025 in Review

PharVision Advisers sold out of Tetra Tech (TTEK) in Q4 2025, closing a stake of 6,517 shares — an estimated $218K sold.

PharVision Advisers first reported a position in TTEK in Q3 2025 and held it in 1 quarter. The position peaked at $218K in Q3 2025. 610 funds tracked by Wall St. Rank hold TTEK as of Q4 2025.

PharVision Advisers reported no remaining Tetra Tech position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 6,517 Tetra Tech shares in Q4 2025, an estimated $218K.
PharVision Advisers first reported a position in Tetra Tech in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Tetra Tech position peaked at $218K in Q3 2025.
610 funds tracked by Wall St. Rank held Tetra Tech as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.